ORIG3N Acquisitions
ORIG3N has acquired 1 company and its latest acquisition was Interleukin Genetics Inc. on Nov 2017
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Interleukin Genetics Inc.
Nov 2017
Source »undisclosed
Interleukin develops and markets proprietary genetic tests for the prevention and management of chronic inflammatory diseases.